KCM
IART icon

Kennedy Capital Management’s Integra LifeSciences IART Stock Holding History

Kennedy Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,625
Closed -$251K – 708
2024
Q2 		$251K Buy
+8,625
New +$256K 0.01% 670
2024
Q1 		– Sell
-24,279
Closed -$1.06M – 745
2023
Q4 		$1.06M Sell
24,279
-38
-0.2% -$1.5K 0.02% 581
2023
Q3 		$929K Sell
24,317
-122
-0.5% -$5.13K 0.02% 569
2023
Q2 		$1.01M Buy
+24,439
New +$1.18M 0.02% 553
2021
Q1 		– Sell
-121,024
Closed -$7.86M – 683
2020
Q4 		$7.86M Sell
121,024
-2,820
-2% -$152K 0.18% 205
2020
Q3 		$5.85M Sell
123,844
-24,402
-16% -$1.16M 0.17% 217
2020
Q2 		$6.97M Sell
148,246
-243
-0.2% -$11.9K 0.2% 162
2020
Q1 		$6.63M Sell
148,489
-104,181
-41% -$5.47M 0.24% 121
2019
Q4 		$14.7M Sell
252,670
-18,439
-7% -$1.1M 0.36% 43
2019
Q3 		$16.3M Buy
271,109
+91,715
+51% +$5.46M 0.4% 33
2019
Q2 		$10M Buy
179,394
+79,378
+79% +$4.09M 0.24% 122
2019
Q1 		$5.57M Buy
100,016
+7,135
+8% +$363K 0.13% 295
2018
Q4 		$4.19M Sell
92,881
-40,914
-31% -$2.24M 0.1% 370
2018
Q3 		$8.81M Buy
+133,795
New +$8.31M 0.16% 218

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kennedy Capital Management's IART Position: Q3 2024 in Review

Kennedy Capital Management sold out of Integra LifeSciences (IART) in Q3 2024, closing a stake of 8,625 shares — an estimated $251K sold.

Kennedy Capital Management first reported a position in IART in Q3 2018 and held it in 14 quarters. The position peaked at $16.3M in Q3 2019. 225 funds tracked by Wall St. Rank hold IART as of Q3 2024.

  • Kennedy Capital Management reported no remaining Integra LifeSciences position as of Q3 2024 after selling out during the quarter.
  • Kennedy Capital Management sold 8,625 Integra LifeSciences shares in Q3 2024, an estimated $251K.
  • Kennedy Capital Management first reported a position in Integra LifeSciences in Q3 2018 and held it in 14 quarters.
  • Kennedy Capital Management's Integra LifeSciences position peaked at $16.3M in Q3 2019.
  • 225 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2024.

Based on Kennedy Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.